CDC

Revive Therapeutics Provides Corporate Update

Retrieved on: 
Tuesday, March 12, 2024
DRDC, Neuroprotection, Tremor, Diazepam, Chronic pain, COVID, Soman, National security, Survival, NAC, Seizure, Partnership, Nervous system, VX, COVID-19, Nerve agent, Patient, Brain, Heart rate, Research, Diarrhea, Endocytosis, RVV, Death, Doctor of Philosophy, Health Canada, Trial of the century, Cough, Traumatic brain injury, CDC, Harvard University, Fever, Sarin, Bleeding, Safety, Chemical warfare, Saliva, Therapy, Disorder, Blurred vision, FDA, Economics, Nerve, Hospital, Pharmaceutical industry

TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today a corporate update on the research, clinical and regulatory initiatives with Bucillamine and its long COVID diagnostic product.

Key Points: 
  • TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today a corporate update on the research, clinical and regulatory initiatives with Bucillamine and its long COVID diagnostic product.
  • Exposure to nerve agents can cause tightness of the chest, excessive salivation, abdominal cramps, diarrhea, blurred vision, tremors, and death.
  • In addition, Revive may evaluate the potential of its proposed long COVID diagnostic product as a companion to Bucillamine.
  • The Company, under its wholly-owned subsidiary Revive Diagnostics Inc., is advancing the product development of a potential blood biomarker diagnostic that characterizes long COVID.

CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago

Retrieved on: 
Tuesday, March 12, 2024
Miami International Airport, Genomics, Federation, Traveler, Pneumonia, JFK, Mycoplasma pneumoniae, Partnership, COVID-19, DNA, MIA, Bacteria, SARS-CoV-2, RSV, Ginkgo Bioworks, Biosecurity, Mycoplasma, CDC, Airport, TGS, Collection, Federal, Vaccine

This expanded funding will also bring the number of airports in the program to a total of nine active sites: Los Angeles, San Francisco, New York (JFK), Washington Dulles, Newark, Boston, Seattle, Miami, and Chicago.

Key Points: 
  • This expanded funding will also bring the number of airports in the program to a total of nine active sites: Los Angeles, San Francisco, New York (JFK), Washington Dulles, Newark, Boston, Seattle, Miami, and Chicago.
  • Since its inception in September 2021, the TGS program has demonstrated its ability to serve as an early detection mechanism for new pathogens and fill gaps in global biosurveillance.
  • In October 2023, the program expanded to cover a list of more than 30 viral and bacterial targets.
  • “We are thrilled to have the opportunity to take the TGS program to the next level.

Fight Colorectal Cancer Unites Over 200 Advocates in Washington, D.C. for the 18th Annual Call-on Congress Event

Retrieved on: 
Tuesday, March 12, 2024
JAMA, Colorectal cancer, Congress, Disease, Caregiver, Incidence, Ageing, Exact sciences, Research, Woman, Statistics, Survivor, CDC, CRC, Large intestine, Dairy

WASHINGTON, D.C., March 12, 2024 (GLOBE NEWSWIRE) -- In a powerful display of unity, Fight Colorectal Cancer (Fight CRC) is hosting the 18th Annual Call-on Congress event, bringing together over 200 colorectal cancer survivors, caregivers, and loved ones.

Key Points: 
  • WASHINGTON, D.C., March 12, 2024 (GLOBE NEWSWIRE) -- In a powerful display of unity, Fight Colorectal Cancer (Fight CRC) is hosting the 18th Annual Call-on Congress event, bringing together over 200 colorectal cancer survivors, caregivers, and loved ones.
  • This landmark advocacy initiative aims to elevate personal stories and press for increased funding and support to combat colorectal cancer (CRC) .
  • Colorectal cancer, encompassing colon and rectal cancers, stands as the second-leading cause of cancer deaths for both men and women combined in the United States.
  • Encouraging Members of Congress to Champion Colorectal Cancer : Advocates will call on their representatives to become champions for colorectal cancer, actively working to transform the statistics surrounding the disease by joining the Colorectal Cancer Caucus.

Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre

Retrieved on: 
Thursday, April 4, 2024
Cardiology, Biotechnology, Pharmaceutical, General Health, Health, Artificial Intelligence, Health Technology, Technology, Cardiovascular disease, Entrepreneurship, Health equity, Partnership, Risk, COVID-19, Patient, AI, Death, CHD, Medicine, CDC, Moyamoya disease, Medicare, McKinsey & Company, Medical device

This collaboration aims to significantly expand access to Cardio Diagnostics' industry-leading, AI-enabled precision cardiovascular diagnostic tests.

Key Points: 
  • This collaboration aims to significantly expand access to Cardio Diagnostics' industry-leading, AI-enabled precision cardiovascular diagnostic tests.
  • By leveraging the rapidly growing telehealth market, Cardio Diagnostics in partnership with Navierre is poised to revolutionize the patient cardiovascular care journey through earlier detection, accessible specialty care, and personalized prevention.
  • "We are thrilled to partner with Navierre to make our industry-leading cardiovascular clinical tests more widely available to patients and clinicians nationwide," said Meesha Dogan, Ph.D., CEO and Co-Founder of Cardio Diagnostics.
  • Cardio Diagnostics and Navierre are dedicated to creating a future where no one is left behind in the fight against cardiovascular disease.

Morris & Dickson is the First U.S. Distributor for Bavarian Nordic’s JYNNEOS®, the Only FDA-approved Mpox Vaccine

Retrieved on: 
Wednesday, April 3, 2024
Infectious Diseases, Pharmaceutical, Health, Disease, Smallpox, Virus, Mpox, Viral disease, Infection, CDC, Bavarian Nordic, Family, FDA, Pharmaceutical industry

Morris & Dickson is proud to announce it is the first U.S. distributor of Bavarian Nordic’s newly launched mpox vaccine, JYNNEOS®.

Key Points: 
  • Morris & Dickson is proud to announce it is the first U.S. distributor of Bavarian Nordic’s newly launched mpox vaccine, JYNNEOS®.
  • As the only FDA-approved mpox vaccine, JYNNEOS is now commercially available in the U.S., marking a significant expansion for access.
  • Bavarian Nordic announced its commercial entry into the US on April 2, noting the ongoing need for the vaccine.
  • “We are proud to be a key partner in expanding access to this first-to-market vaccine,” says Layne Martin, head of Specialty at Morris & Dickson.

Paul Martino, Co-Founder of VillageMD, Joins Parsley Health as Chair of the Board

Retrieved on: 
Wednesday, April 3, 2024
Telemedicine, Virtual Medicine, Alternative Medicine, Managed Care, General Health, Health, Health Technology, Health Insurance, Fitness & Nutrition, TME, Chair, Innovation, Entrepreneurship, Kinnevik AB, Partnership, Patient, Conditional sentence, Chairperson, Columbia, Digital health, MD, Insurance, Actuary, Investment, CDC, Blue Shield, Frontiers, CMO, Nursing

Parsley Health , a digital health company designed to improve health status and lower costs in patients with complex and chronic conditions using root cause medicine, today announced that accomplished healthcare executive, Paul Martino, has been appointed as Chair of the Board.

Key Points: 
  • Parsley Health , a digital health company designed to improve health status and lower costs in patients with complex and chronic conditions using root cause medicine, today announced that accomplished healthcare executive, Paul Martino, has been appointed as Chair of the Board.
  • "Parsley Health simplifies complex health care, manages costs and ultimately helps patients live healthier lives,” said Paul Martino.
  • His leadership and partnership will be instrumental in accelerating Parsley’s growth,” said Dr. Robin Berzin, M.D., Founder, and CEO of Parsley Health.
  • Founded in 2016 by Dr. Robin Berzin, MD, a Columbia-trained physician and digital health expert, Parsley Health originally opened with brick-and-mortar centers in New York and California.

Byzantine State Regulations Delay Vaccine Access at Pharmacies, Global Healthy Living Foundation Study Reveals

Retrieved on: 
Tuesday, April 2, 2024
Science, Public Policy, Government, Biotechnology, Research, Pharmaceutical, General Health, Health, Healthcare Reform, Second Continental Congress, Conditional sentence, Congress, Innovation, Fellow, Policy, Data science, Doctor of Pharmacy, Associate, Physician, Risk, Patient, Pharmacy, Social media, Pharmacist, Doctor of Philosophy, RSV, Health policy, Pacific Research Institute, Publication, CDC, Vaccination, Safety, Vaccine, PRI, FDA, Economics, Legislation

The research shines a light on the significant obstacles faced by pharmacists, who are often the most accessible health care providers for vaccinations.

Key Points: 
  • The research shines a light on the significant obstacles faced by pharmacists, who are often the most accessible health care providers for vaccinations.
  • “Post-pandemic data unequivocally reveals adult patients' preference for vaccinations at pharmacies, with nearly 90 percent of immunizations provided by pharmacists or pharmacy technicians.
  • This situation is particularly troubling for patients in low-income communities who have better access to pharmacies than health care provider practices.
  • Such a move would promote equity in health care access and elevate vaccination rates to recommended levels.

China Passenger Car Electronic Control Suspension Industry Research Report 2024 Featuring 15 Electronic Control Suspension Suppliers and 15 Domestic Passenger Cars Companies - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 2, 2024
Technology, EV, Electric Vehicles, Automotive, Consumer Electronics, BODY, Air suspension, NIO, BYD, Camping, Mercedes-Benz, Chang'an, ADAS, ASU, Statistics, BMW, CDC, Atmosphere, MAGIC, Magic

The "China Passenger Car Electronic Control Suspension Industry Research Report, 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "China Passenger Car Electronic Control Suspension Industry Research Report, 2024" report has been added to ResearchAndMarkets.com's offering.
  • Electronic Control Suspension can be divided into full active suspension and semi-active suspension according to whether it contains power source.
  • Full active suspension contains power source, usually refers to as 'active suspension'; Semi-active suspension or passive active suspension does not contain power source.
  • Active suspension can adjust two parameters of suspension damping and stiffness, while semi-active suspension can adjust one of the two parameters.

EarliTec Diagnostics, Inc. Raises $21.5 Million in Series B Financing; Funds to Accelerate Commercialization of EarliPoint Evaluation and Further Product Development

Retrieved on: 
Tuesday, April 2, 2024
Neurology, Biometrics, Health, Mental Health, Medical Devices, Children, Health Technology, Consumer, Nexus, Diagnosis, Professor, Ageing, Child, Hope, CDC, Spectrum, Multimedia

The funds will be used to expand commercialization efforts and advance clinical research for the first-in-kind EarliPoint™ Evaluation (“EarliPoint”), which aids clinicians in the diagnosis and assessment of autism in children aged 16-to-30 months.

Key Points: 
  • The funds will be used to expand commercialization efforts and advance clinical research for the first-in-kind EarliPoint™ Evaluation (“EarliPoint”), which aids clinicians in the diagnosis and assessment of autism in children aged 16-to-30 months.
  • EarliPoint is the first personalized, quantifiable, and objective tool for children aged 16 months to 30 months suspected of having autism.
  • "EarliPoint represents a meaningful step forward in better, accessible care for autistic children.
  • "We are excited to partner with providers across the nation to deliver EarliPoint.

Ververica to Talk Big Data Solutions at the Big Data Technology Warsaw Summit

Retrieved on: 
Tuesday, April 2, 2024
Professional Services, Data Management, Technology, Data Analytics, Software, Internet, Cloud, Cloud computing, CDC, Apache Flink, VERA

Ververica , a comprehensive streaming data platform, is excited to announce its participation as a Content Partner sponsor at the upcoming Big Data Technology Warsaw Summit.

Key Points: 
  • Ververica , a comprehensive streaming data platform, is excited to announce its participation as a Content Partner sponsor at the upcoming Big Data Technology Warsaw Summit.
  • This event, renowned for gathering the experts in big data, cloud computing, and data analytics, will serve as leverage for Ververica to showcase Ververica Cloud, including the innovative VERA (Ververica Runtime Assembly) Technology.
  • During the summit, Ververica will feature prominently in both presentations and technical workshops, aimed at demonstrating the power and flexibility of Ververica’s streaming data platform solutions:
    Session: “Real-time Clickstream Analytics on E-commerce Website Data using Ververica Cloud”: Showcasing how Ververica Cloud, empowered by VERA Technology, is revolutionizing the e-commerce sector through enhanced real-time data analytics capabilities.
  • Attendees of the Big Data Technology Warsaw Summit will have the opportunity to connect directly with Ververica’s team of experts during the conference.